Skip to content

Developing a Down Syndrome Health Instrument

Developing a Down Syndrome Health Instrument

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04631237
Enrollment
758
Registered
2020-11-17
Start date
2020-04-03
Completion date
2025-03-31
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Down Syndrome, Health, Subjective

Keywords

health status

Brief summary

Although over 200,000 individuals with DS live in the United States, studies to date have focused on outcomes apart from health. The foundation for this proposal is based on the need to accurately measure health of all individuals - specifically, with DS - and the dearth of available tools for this population. Creating such an instrument will provide a barometer of the current state of health for DS and hold use in future research. In this project, I propose to create an instrument that directly assesses health in DS - the Down syndrome Health Instrument (DHI). More specifically, the aims of this proposal are: 1. To conduct focus groups among caregivers, individuals with DS, panels of experts on DS and primary care physicians, and cognitive interviews to refine a conceptual model of health for DS and create an item pool, 2. To administer the DHI and establish internal validity, reliability, and external validity of the DHI for use in clinical research, and 3. To test the usability of the DHI in two pilot settings: research and clinical. This instrument will measure patient-reported health in DS for the first time and allow measurement of health as an outcome which is not currently possible in this population. This can identify gaps in care, then direct and optimize interventions that will improve care.

Interventions

No intervention involved

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER
National Institutes of Health (NIH)
CollaboratorNIH

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Primary caregiver of an individual with DS (individual with DS age: \<22 years) * Caregiver age: ≥18 years * Fluent in written and spoken English * Able to read and provide informed consent

Exclusion criteria

* Physical or mental condition of caregiver that would prohibit self-administration of questionnaire * Mosaic Down syndrome: based on medical record review. If caregiver is uncertain or mosaicism is unknown, we will request additional records.

Design outcomes

Primary

MeasureTime frameDescription
Number of Completed Surveys for Validation AnalysisAt the time of survey completionLocal and national survey results, cognitive interviews and validation of Down syndrome health measure (DSHM) using psychometric analysis and factor analysis

Secondary

MeasureTime frameDescription
Number of Focus Group Participants Who Participated to Make the Conceptual ModelAt the time of focus group completionDescriptive focus group results regarding health views. Outline of the preliminary conceptual model
Number of Completed Cognitive InterviewsAt the time of cognitive interview

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORSTEPHANIE L SANTORO, MD

MGH

Participant flow

Pre-assignment details

Some individuals who started the survey did not elect to complete it / reach the end of the survey. Only participants who had made it through the whole survey / to the end were included in analysis.

Baseline characteristics

Characteristic
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
688 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
33 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
36 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
28 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
Race (NIH/OMB)
Asian
13 Participants
Race (NIH/OMB)
Black or African American
18 Participants
Race (NIH/OMB)
More than one race
11 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
4 Participants
Race (NIH/OMB)
Unknown or Not Reported
157 Participants
Race (NIH/OMB)
White
546 Participants
Sex: Female, Male
Female
23 Participants
Sex: Female, Male
Male
5 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 280 / 420 / 542
other
Total, other adverse events
0 / 280 / 420 / 542
serious
Total, serious adverse events
0 / 280 / 420 / 542

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 10, 2026